This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Varicella Zoster Infection Treatment Market

Market Insights on Varicella Zoster Infection Treatment covering sales outlook, demand forecast & up-to-date key trends

Varicella Zoster Infection Treatment Market by Drug Type (Acyclovir, Valacyclovir and Famciclovir), by Route of Administration (Oral, Topical & Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Drug Stores) and by Region, Forecast for 2022 - 2028

Varicella Zoster Infection Treatment Market Snapshot

[276 Pages Report] The global Varicella Zoster Infection Treatment Market in 2020 is estimated for more than US$ 1.5 Bn and expected to reach a value of US$ 2.0 Bn by 2028 with a significant CAGR of 4.1%. As per Future Market Insights’ projections, in 2022, the acyclovir holds a substantial share of over 55.7% in the overall varicella zoster infection treatment market.

Human alphaherpesvirus 3, also known as Varicella Zoster virus (VZV) is one of the many herpesviruses that is known to infect humans.  It is also the one causing infectious diseases like chicken pox (which is mostly common among children and teens) and herpes zoster (shingles) (mostly affecting adults but rarely in children).  The growing incidence of herpes zoster (shingles) infection among the children’s and the elderly and the rising demand towards the treatment of the infection is aiding the growth of the market.

Market Outlook:

Data Points

Market Insights

Market Value 2022

US$ 1.61 Bn

Market Value 2028

US$ 2.05 Bn

CAGR 2022-2028

4.1%

Share of top 5 Countries

52.3%

Key Players

Novartis AG, Pfizer Inc., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Valeant Pharmaceuticals International Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, ltd., Mylan N.V.  and GlaxoSmithKline plc and Others  (100% Market Share)

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

4.17%

H1, 2022 Projected

4.11%

H1, 2022 Outlook

4.01%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 16 ↓

A comparative analysis about the market growth rates and development prospects in the global varicella zoster infection treatment market have been mapped by Future Market Insights. According to the FMI analysis, compared to H1-2021, the market is expected to decline by 16 Basis Point Share (BPS) in H1 2022 (O).

Major reasons for this dip in BPS are attributed to the adverse effects of antiviral therapy which include neurological, gastrointestinal, and renal toxicity. The market further observes a decline in 10 BPS in H1-2022 outlook as compared to H1-2022 projected period.

The market is subject to be influenced by regulatory guidelines and medical device approvals in accordance with impact of macro, economic, and industry factors. Prevention of varicella zoster infection through vaccination strategies permits the avoidance of primary infections in neonates and vulnerable cases. These are some of the significant breakthroughs in the varicella zoster infection treatment market.

Other market segments are correspondingly set to perform objectively and attain promising growth prospects in the next half of projection period. Additionally, there are some factors which positively drive the industry growth, including the improvement of cell medicated immunity after second administration of varicella vaccine, and long-lasting immunity response of live attenuated vaccines.

2016-2021 Varicella Zoster Infection Treatment Demand Outlook Compared to 2022-2028 Forecast

The Global varicella zoster infection treatment market is expected to grow at a modest rate during the forecast period. The epidemiology of the varicella infection is higher in children aged 4-10 year. However, Herpes zoster occur due to reactivation of varicella zoster virus in older age, where, the incidence is higher in older age population >60 years compared to adults and children.

For instance, in 2021, United States (US) reported that the risk of Herpes Zoster increases with age. A cumulative incidence of Herpes Zoster were reported to be from 2.9–19.5 cases per 1,000 population and an incidence rate of Herpes Zoster ranging from 5.23–10.9 cases per 1,000 person-years. It is been expected that the incidence of herpes zoster in these countries will increase with increasing older age population.

Varicella Zoster Infection Treatment Market Download Report Brochure

The Global Varicella Zoster Infection Treatment market constitutes nearly 3% of the ~52.7 Bn Antiviral Drugs Market, globally in 2021. Herpes zoster is not common in children younger than 1 year and is rarely found in children’ younger than 1 year. However, if a pregnant female witness’s varicella zoster infection during pregnancy, there are high chances of the fetus developing asymptomatic congenital infections. Such children generally present herpes zoster within the first year of their life. Furthermore, the growing risk of prenatal varicella zoster leads to the uptake of antiviral drugs treatment later in pregnancy. Thus, the growing risk of postnatal varicella zoster infection in children younger than 1 year of age and the subsequent use of acyclovir as the first line of treatment for these infected children will drive the growth of varicella zoster infection treatment market in future.

Hence, the demand outlook for varicella zoster infection treatment market is expected to grow rapidly during the forecast period from 2022- 2028 owing to the growing demand for effective drug treatments for varicella zoster infections.

The market is expected to expand at a considerable growth rate for the period 2022-2028 at a CAGR of approximately 4.1%, and observe an incremental $ opportunity of USD 438.6 Mn from 2022 to 2028. Demand for Acyclovir drug as a first line treatment will remain the maximum throughout the forecast period.

What are the Key Opportunities for Market Players?

The increasing incidences of viral borne disease among children and old population, high transmission rate of the infection, high occurrence of infections in low or middle-income countries and growing revenue of the market players are the major factors contributing to the growth of the varicella zoster infection treatment market.

The companies in the varicella zoster infection treatment market are focusing on organic and inorganic growth by launching their products and to gain maximum market share.  Moreover, acquisitions, expansion of product portfolio and research & development capabilities are expected to create opportunities for the growth of the market.

  • For instance, in July 2021, US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who will be at increased risk of shingles due to immunodeficiency or immunosuppression.
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the key challenges to Varicella Zoster Infection Treatment Market?

The adverse effect of anti-viral therapy treatment among the elderly population presents a biggest challenge for the market to grow ahead, the elderly care itself is an intensive care segment and onset of viral diseases like Herpes Zoster increases the risk of associated infections and other reactions.

Moreover, availability of other treatment options for treating the herpes zoster and varicella such as homeopathy, supplements and other natural herbal medicines may also come out as a bigger challenge for the varicella zoster infection treatment market. A clinical study done in China also revealed that the modified Gentiana formula when combined with the topical cream as a treatment for post-herpetic neuralgia, was more effective than the antiviral drugs treatment. Additionally, introduction of generic drugs by the local players in large number together with rising cases of product recalls of many such drugs are leading to create quality concern of these generic drugs amongst the consumers. All such factors together may pose greater challenges for the varicella zoster infection treatment market growth during the forecast period.

What is the Impact of the COVID-19 Crisis on the Market?

The COVID-19 outbreak initially affected the market negatively due to the lockdowns that were imposed in the first half of 2020, which resulted in disruption of the supply chain. Also, fall in number of surgeries and reduced patient visits to the hospitals due to change in healthcare priorities and also as a prevention measure to avoid contracting the disease also resulted in drop in the number of patients visiting hospitals for disease other than COVID-19.

However, with the opening of all the economies and the people now adapting to the new normal the market is been expected to achieve significant growth during the forecast period. Companies are revising their long-term strategies to develop adequate crisis-management strategies that place a premium on next-generation products and solutions, varicella zoster

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will the U.S. Remain a Key Market for Varicella Zoster Infection Market?

The U.S. is the leading country of the North American region with a total market value share of 90.3% in 2021 and is projected to continue commanding the high growth during the coming years from 2022- 2028. The deep incidence of herpes infection among children mainly drives the growth of this market & their humanization and increasing pets disorder owing to rise in disease incidence.

For instance, as per Centre for Diseases Prevention and Control, an estimated one million cases of herpes zoster occur annually in the United States. The incidence for herpes zoster is approximately 4 cases per 1,000 U.S. population annually.

Additionally, presence of major players involved in the commercialization and development of herpes zoster interventions is also one of the major factor for the growth of this market in this region.

Why is Germany Considered a More Lucrative Market within Europe?

Germany dominates the Western Europe market of varicella zoster, with a share of nearly 24.7% of the market share by value in 2021. Similar growth is expected throughout the forecast period owing to the higher prevalence of herpes and increasing research and development activities which is also contributing to the varicella zoster infection treatment market growth in the region.  

For instance, the incidence of HZ in Germany ranges from about 1/1,000 in children aged less than 10 years, to more than 10/1,000 in persons aged 80 years and older; the incidence becomes distinctly higher in persons from 50 years onwards.

Why is Japan an Emerging Market for Varicella zoster infection treatment?

In 2021, Japan holds around 6.9% share in the global market by value and is been estimated to expand at a CAGR of 2.7% during the forecast period. The rising incidence of Herpes Zoster in the general population aged ≥ 50 or ≥ 60 years in the country leads to enhance the demand of varicella zoster infection treatment.

Additionally, rising government funding and support for vaccination and awareness campaigns are expected to propel the varicella zoster infection treatment market forward throughout the projection period.

What is the Outlook in China for the Varicella Zoster Infection Treatment Market?

In 2021, China has considerable share by value in the global market ranging around 8.7% and is been projected to expand at a CAGR of 4.5% from 2022-2028. This is predominantly due to the increasing risk of herpes zoster among the elderly population. Approximately, 32% of the Chinese population is aged 50 years and older and this proportion is increasing. Because of the ageing population, the public burden associated with shingles is been expected to increase over the time.

Category-wise Insights

Which Varicella Zoster Infection Treatment Product is driving the market growth?

By product, acyclovir drug accounts for the highest share of around 55.9% in 2021 and expected to expand at a CAGR of 3.7% during the forecast period from 2022 - 2028. 

Acyclovir presents the broader scope for the treatment of herpes zoster. It is also used to treat repeat outbreaks to prevent further outbreaks of genital herpes (a herpes virus infection that causes sores to form around the genitals and rectum from time to time) in people with a normal immune system. Famciclovir is also used to treat returning herpes simplex infections of the skin and mucus membranes (mouth, anus) in people with human immunodeficiency virus (HIV) infection

Owing to its broader benefits, the varicella zoster infection treatment market is experiencing its faster adoption, resulting in driving the demand for the drug in the varicella zoster infection treatment during the forecast period from 2022-2028.

Why does the Oral route of drug administration hold a High Market Share?

The Oral route for drug administration dominates the varicella zoster infection treatment market, with a 64.3% of the revenue share in 2021. This trend is expected to continue to grow during the study period. The high share of this segment is been attributed to its inherited safety, higher absorption and increased usage in the procedures and related treatment.

Which Distribution Channel is leading the Global Varicella Zoster Infection Treatment Market?

Based on the distribution channel, hospital pharmacies is the leading segment, with 43% market share in 2021 and expanding at a CAGR of 3.9% in the forecast period. Growing number of herpes zoster treatments in the hospitals and availability of medicines in the hospital pharmacies, as these medicines can only be bought if prescribed by a doctor or medical practitioner, will provide lucrative opportunities for varicella zoster infection treatment market growth.

Competitive Landscape

The key companies are focusing on regulatory approvals, new drug launches and marketing of their brands to get more attention and gain maximum market share. Additionally, acquisitions, mergers and strategic collaborations play a vital role in the growth of the varicella zoster infection treatment market.

  • For Instance: In April 2017, Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. FDA for Acyclovir Ointment USP, 5%  is the first generic version of Valeant International's Zovirax Ointment
  • In December 2016, Slayback and Sandoz signed an agreement for the sale and marketing rights of Slayback Generic Zovirax Ointment (Acyclovir Ointment). Due to the agreement, Novartis got the sale and marketing rights, which augmented their position in the market.

In Dec 2015, Valeant Pharmaceuticals International, Inc. announced new fulfillment agreements with Walgreens. Due to these agreements, the company forayed into retail business pharmacies

Scope of the Report

Attribute

Details

Forecast Period

2022-2028

Historical Data Available for

2012-2021

Market Analysis

USD Million for Value, Units for Volume

Key Countries Covered

US, Canada,  Brazil,  Mexico, Argentina, Germany, U.K., France, Italy, Spain,  Benelux, Russia, China, Japan, India, ASEAN, Australia, New Zealand, and GCC Countries

Key Segments Covered

Drug Type, Route of Administration, Distribution Channel, and Region

Key Companies Profiled

  • Novartis AG,
  • Pfizer Inc.,
  • Abbott Laboratories,
  • Sun Pharmaceuticals Industries Ltd.,
  • Valeant Pharmaceuticals International Inc.,
  • Teva Pharmaceutical Industries Ltd.,
  • Dr. Reddy’s Laboratories, ltd.,
  • Mylan N.V.  and
  • GlaxoSmithKline

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Varicella Zoster Infection Treatment - Market Segmentation - by Category

By Drug Type:

  • Acyclovir
  • Valacyclovir
  • Famciclovir

By Route of Administration:

  • Oral
  • Injectable
  • Topical

By Distribution Channel:

  • Hospital pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APECJ
  • China
  • Japan
  • Middle East Africa

Frequently Asked Questions

The varicella zoster infection treatment based market is worth at US$ 1.54 Bn in the year 2021 and is been expected to reach US$ 2.04 Bn by 2028

Acyclovir drug is been projected to reflect high demand in the forecast period with a CAGR of 3.7%.

Increasing cases of herpes zoster in developed and developing countries, growing focus on clinical development of antiviral drugs, concerting efforts in mitigating the economic burden of varicella zoster virus Infection and growing adoption of effective anti-viral drug treatment are some of the trends that will fuel the demand for Varicella zoster.

The cumulative market share of the top countries constitutes nearly 52.3% of the overall global market share.

U.S., China, Japan, Germany, and UK are the top 5 countries which are driving the demand for Varicella zoster.

Western Europe’s market is forecasted to grow at a CAGR of 3.6% between 2022- 2028. Germany being dominant country in term of revenue in European market of varicella zoster.

The APECJ market is set to exhibit a market share of over 11.0% of the global market value during the forecast period.

Novartis AG, Pfizer Inc., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd are the key producers in this market.

Table of Content

1. Executive Summary

    1.1. Market Overview

    1.2. Market Analysis

    1.3. Wheel of Fortune

2. Market Introduction

    2.1. Market Definition

    2.2. Market Taxonomy

3. Varicella Zoster Infection Treatment Market Opportunity Analysis 

    3.1. Macro-Economic Factors

    3.2. Opportunity Analysis

4. Market Background

    4.1. Market Dynamics

        4.1.1. Drivers

        4.1.2. Restraints

5. Global Economic Outlook

    5.1. Disease Outlook

6. Key Inclusions

    6.1. Key Manufacture List

    6.2. Prescription Pattern

7. North America Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    7.1. Introduction

    7.2. Regional Market Trends

    7.3. Regional Scenario

    7.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        7.4.1. U.S.

        7.4.2. Canada

    7.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    7.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        7.6.1. Acyclovir

        7.6.2. Valacyclovir

        7.6.3. Famciclovir

    7.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    7.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        7.8.1. Oral

        7.8.2. Topical

        7.8.3. Injectable

    7.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    7.10. Historical Market Size (US$ Mn) and Volume Trend Analysis By Distribution Channel, 2012-2021

        7.10.1. Hospital Pharmacies

        7.10.2. Retail Pharmacies

        7.10.3. Online Pharmacies

        7.10.4. Drug Stores

    7.11. Market Size (US$ Mn) and Volume Forecast By Distribution Channel, 2022-2028

    7.12. Market Attractiveness Analysis

        7.12.1. By Country

        7.12.2. By Drug Type

        7.12.3. By Route of Administration

        7.12.4. By Distribution Channel

    7.13. Key Market Participants – Intensity Mapping

8. Latin America Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    8.1. Introduction

    8.2. Regional Market Trends

    8.3. Regional Scenario

    8.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        8.4.1. Brazil

        8.4.2. Mexico

        8.4.3. Rest of Latin America

    8.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    8.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        8.6.1. Acyclovir

        8.6.2. Valacyclovir

        8.6.3. Famciclovir

    8.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    8.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        8.8.1. Oral

        8.8.2. Topical

        8.8.3. Injectable

    8.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    8.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        8.10.1. Hospital Pharmacies

        8.10.2. Retail Pharmacies

        8.10.3. Online Pharmacies

        8.10.4. Drug Stores

    8.11. Market Size (US$ Mn Forecast By Distribution Channel, 2022-2028

    8.12. Market Attractiveness Analysis

        8.12.1. By Country

        8.12.2. By Drug Type

        8.12.3. By Route of Administration

        8.12.4. By Distribution Channel

    8.13. Key Market Participants – Intensity Mapping

9. Western Europe Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    9.1. Introduction

    9.2. Regional Market Trends

    9.3. Regional Scenario

    9.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        9.4.1. Germany

        9.4.2. U.K.

        9.4.3. France

        9.4.4. Italy

        9.4.5. Spain

        9.4.6. Rest of Western Europe

    9.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    9.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        9.6.1. Acyclovir

        9.6.2. Valacyclovir

        9.6.3. Famciclovir

    9.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    9.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        9.8.1. Oral

        9.8.2. Topical

        9.8.3. Injectable

    9.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    9.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        9.10.1. Hospital Pharmacies

        9.10.2. Retail Pharmacies

        9.10.3. Online Pharmacies

        9.10.4. Drug Stores

    9.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    9.12. Market Attractiveness Analysis

        9.12.1. By Country

        9.12.2. By Drug Type

        9.12.3. By Route of Administration

        9.12.4. By Distribution Channel

    9.13. Key Market Participants – Intensity Mapping

10. Eastern Europe Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    10.1. Introduction

    10.2. Regional Market Trends

    10.3. Regional Scenario

    10.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        10.4.1. Russia

        10.4.2. Poland

        10.4.3. Rest of Eastern

    10.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    10.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        10.6.1. Acyclovir

        10.6.2. Valacyclovir

        10.6.3. Famciclovir

    10.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    10.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        10.8.1. Oral

        10.8.2. Topical

        10.8.3. Injectable

    10.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    10.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        10.10.1. Hospital Pharmacies

        10.10.2. Retail Pharmacies

        10.10.3. Online Pharmacies

        10.10.4. Drug Stores

    10.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    10.12. Market Attractiveness Analysis

        10.12.1. By Country

        10.12.2. By Drug Type

        10.12.3. By Route of Administration

        10.12.4. By Distribution Channel

    10.13. Key Market Participants – Intensity Mapping

11. Asia Pacific Excluding China & Japan Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    11.1. Introduction

    11.2. Regional Scenario

    11.3. Regional Market Trends

    11.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2021

        11.4.1. India

        11.4.2. Australia and New Zealand

        11.4.3. ASEAN

        11.4.4. Rest of APECJ

    11.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    11.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        11.6.1. Acyclovir

        11.6.2. Valacyclovir

        11.6.3. Famciclovir

    11.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    11.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        11.8.1. Oral

        11.8.2. Topical

        11.8.3. Injectable

    11.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    11.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        11.10.1. Hospital Pharmacies

        11.10.2. Retail Pharmacies

        11.10.3. Online Pharmacies

        11.10.4. Drug Stores

    11.11. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    11.12. Market Attractiveness Analysis

        11.12.1. By Country

        11.12.2. By Drug Type

        11.12.3. By Route of Administration

        11.12.4. By Distribution Channel

    11.13. Key Market Participants – Intensity Mapping

12. China Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    12.1. Introduction

    12.2. Key Regulations

    12.3. Regional Market Trends

    12.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        12.4.1. Acyclovir

        12.4.2. Valacyclovir

        12.4.3. Famciclovir

    12.5. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    12.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        12.6.1. Oral

        12.6.2. Topical

        12.6.3. Injectable

    12.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    12.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        12.8.1. Hospital Pharmacies

        12.8.2. Retail Pharmacies

        12.8.3. Online Pharmacies

        12.8.4. Drug Stores

    12.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    12.10. Market Attractiveness Analysis

        12.10.1. By Country

        12.10.2. By Drug Type

        12.10.3. By Route of Administration

        12.10.4. By Distribution Channel

    12.11. Key Market Participants – Intensity Mapping

13. Japan Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    13.1. Introduction

    13.2. Key Regulations

    13.3. Regional Market Trends

    13.4. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        13.4.1. Acyclovir

        13.4.2. Valacyclovir

        13.4.3. Famciclovir

    13.5. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    13.6. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        13.6.1. Oral

        13.6.2. Topical

        13.6.3. Injectable

    13.7. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    13.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        13.8.1. Hospital Pharmacies

        13.8.2. Retail Pharmacies

        13.8.3. Online Pharmacies

        13.8.4. Drug Stores

    13.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2022-2028

    13.10. Market Attractiveness Analysis

        13.10.1. By Country

        13.10.2. By Drug Type

        13.10.3. By Route of Administration

        13.10.4. By Distribution Channel

    13.11. Key Market Participants – Intensity Mapping

14. Middle East & Africa Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    14.1. Introduction

    14.2. Regional Scenario

    14.3. Regional Market Trends

    14.4. Historical Market Size (US$ Mn) Analysis By Country, 2012-2021

        14.4.1. GCC Countries

        14.4.2. North Africa

        14.4.3. South Africa

        14.4.4. Rest of MEA

    14.5. Market Size (US$ Mn) Forecast By Country, 2022-2028

    14.6. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        14.6.1. Acyclovir

        14.6.2. Valacyclovir

        14.6.3. Famciclovir

    14.7. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    14.8. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        14.8.1. Oral

        14.8.2. Topical

        14.8.3. Injectable

    14.9. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    14.10. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        14.10.1. Hospital Pharmacies

        14.10.2. Retail Pharmacies

        14.10.3. Online Pharmacies

        14.10.4. Drug Stores

    14.11. Market Size (US$ Mn) By Distribution Channel, 2022-2028

    14.12. Market Attractiveness Analysis

        14.12.1. By Country

        14.12.2. By Drug Type

        14.12.3. By Route of Administration

        14.12.4. By Distribution Channel

    14.13. Key Market Participants – Intensity Mapping

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

        17.2.1. Teva Pharmaceutical Industries Ltd.

        17.2.2. Abbott Laboratories

        17.2.3. Sun Pharmaceuticals Industries Ltd.

        17.2.4. Mylan N.V.

        17.2.5. Pfizer Inc.

        17.2.6. GlaxoSmithKline plc.

        17.2.7. Dr. Reddy’s Laboratories, ltd.

        17.2.8. Novartis AG

        17.2.9. Valeant Pharmaceuticals International Inc.

18. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Region

    18.1. Introduction/Key Findings

    18.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021

    18.3. Market Size (US$ Mn) Forecast By Region, 2022-2028

        18.3.1. North America

        18.3.2. Latin America

        18.3.3. Western Europe

        18.3.4. Eastern Europe

        18.3.5. Asia Pacific Excluding China & Japan

        18.3.6. China

        18.3.7. Japan

        18.3.8. Middle East & Africa

    18.4. Market Attractiveness Analysis By Region

19. Global Varicella Zoster Infection Treatment Analysis 2012-2021 and Forecast 2022-2028, By Drug Type

    19.1. Introduction/Key Findings

    19.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2012-2021

        19.2.1. Acyclovir

        19.2.2. Valacyclovir

        19.2.3. Famciclovir

    19.3. Market Size (US$ Mn) Forecast By Drug Type, 2022-2028

    19.4. Market Attractiveness Analysis By Drug Type

20. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Route of Administration

    20.1. Introduction/Key Findings

    20.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2012-2021

        20.2.1. Oral

        20.2.2. Topical

        20.2.3. Injectable

    20.3. Market Size (US$ Mn) Forecast By Route of Administration, 2022-2028

    20.4. Market Attractiveness Analysis By Route of Administration

21. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028, By Distribution Channel

    21.1. Introduction/Key Findings

    21.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012-2021

        21.2.1. Hospital Pharmacies

        21.2.2. Retail Pharmacies

        21.2.3. Online Pharmacies

        21.2.4. Drug Stores

    21.3. Market Size (US$ Mn) By Distribution Channel, 2022-2028

    21.4. Market Attractiveness Analysis By Distribution Channel

22. Global Varicella Zoster Infection Treatment Market Analysis 2012-2021 and Forecast 2022-2028

    22.1. Market Value Share Analysis By All Segment

    22.2. Y-o-Y Growth Analysis By All Segment

    22.3. Absolute $ Opportunity

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 02: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 03: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 04: North America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 05: North America Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 06: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 07: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 08: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 09: Latin America Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 10: Latin America Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 11: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 12: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 13: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 14: Western Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 15: Western Europe Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 16: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 17: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 18: Eastern Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 19: Eastern Europe Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 20: Eastern Europe Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 21: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 22: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 23: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 24: APECJ Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 25: APECJ Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 26: China Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 27: China Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 28: China Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 29: China Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 30: Japan Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 31: Japan Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 32: Japan Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 33: Japan Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 34: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Country

Table 35: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Drug Type

Table 36: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Route of Administration

Table 37: MEA Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis-2012-2021 and Forecast 2022-2028, By Distribution Channel

Table 38: MEA Varicella Zoster Infection Treatment Market Participants Presence (Intensity Mapping)

Table 39: Global Varicella Zoster Infection Treatment Market Size (US$ Mn) Forecast By Region, 2022-2028

Table 40: Global Varicella Zoster Infection Treatment Market size Value (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Drug Type

Table 41: Global Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Route of Administration

Table 42: Global Varicella Zoster Infection Treatment Market size (US$ Mn) Analysis 2012-2021 and Forecast 2022-2028, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Varicella Zoster Infection Treatment Market Value Share By Drug Type 2021 (A)

Figure 02: Global Varicella Zoster Infection Treatment Market Value Share By Route of Administration 2021 (A)

Figure 03: Global Varicella Zoster Infection Treatment Market Value Share By Distribution Channel 2021 (A)

Figure 04: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 05: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 06: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 07: Varicella Zoster Infection Treatment Market Split By Country (2021)

Figure 08: North America Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 09: North America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 10: U.S. Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 11: U.S. Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 12: Canada Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 13: Canada Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 14: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 15: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 16: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 17: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 18: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 19: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 20: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 21: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 22: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 23: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 24: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 25: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 26: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 27: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 28: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 29: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 30: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 31: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 32: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 33: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 34: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 35: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 36: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 37: North America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 38: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 39: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 40: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 41: Varicella Zoster Infection Treatment Market Split By Country (2021)

Figure 42: Latin America Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 43: Latin America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 44: Brazil Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 45: Brazil Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 46: Mexico Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 47: Mexico Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 48: Rest of Latin America Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 49: Rest of Latin America Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 50: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 51: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 52: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 53: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 54: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 55: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 56: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 57: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 58: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 59: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 60: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 61: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 62: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 63: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 64: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 65: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 66: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 67: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 68: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 69: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 70: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 71: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 72: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 73: Latin America Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 74: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 75: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 76: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 77: Varicella Zoster Infection Treatment Market Split By Country (2021)

Figure 78: Western Europe Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 79: Western Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 80: Germany Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 81: Germany Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 82: U.K. Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 83: U.K. Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 84: France Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 85: France Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 86: Italy Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 87: Italy Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 88: Spain Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 89: Spain Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 90: Rest of Western Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 91: Rest of Western Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 92: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 93: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 94: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 95: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 96: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 97: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 98: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 99: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 100: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 101: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 102: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 103: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 104: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 105: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 106: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 107: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 108: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 109: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 110: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 111: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 112: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 113: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 114: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 115: Western Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 116: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 117: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 118: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 119: Varicella Zoster Infection Treatment Market Split By Country (2021)

Figure 120: Eastern Europe Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 121: Eastern Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 122: Russia Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 123: Russia Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 124: Poland Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 125: Poland Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 126: Rest of Eastern Europe Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 127: Rest of Eastern Europe Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 128: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 129: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 130: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 131: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 132: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 133: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 134: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 135: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 136: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 137: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 138: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 139: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 140: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 141: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 142: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 143: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 144: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 145: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 146: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 147: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 148: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 149: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of

Administration, 2022-2028

Figure 150: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 151: Eastern Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 152: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 153: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 154: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 155: Varicella Zoster Infection Treatment Market Split By Country (2021)

Figure 156: APECJ Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 157: APECJ Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 158: India Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 159: India Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 160: Australia & New Zealand Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 161: Australia & New Zealand Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 162: ASEAN Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 163: ASEAN Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 164: Rest of APEJ Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 165: Rest of APEJ Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 166: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 167: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 168: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 169: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 170: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 171: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 172: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 173: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 174: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 175: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 176: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 177: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 178: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 179: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 180: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 181: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 182: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 183: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 184: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 185: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 186: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 187: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 188: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 189: APECJ Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 190: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 191: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 192: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 193: China Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 194: China Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 195: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 196: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 197: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 198: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 199: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 200: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 201: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 202: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 204: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 205: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 206: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 207: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 208: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 209: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 210: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 211: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 212: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 213: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 214: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 215: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 216: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 217: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 218: China Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel,2022-2028

Figure 219: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 220: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 221: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 222: Japan Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 223: Japan Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 224: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 225: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 226: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 227: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 228: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 229: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 230: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 231: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 232: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 233: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 234: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 235: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 236: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 237: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 238: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 239: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 240: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 241: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 242: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 243: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 244: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 245: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration,2022-2028

Figure 246: Japan Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 247: Varicella Zoster Infection Treatment Market Split By Drug Type (2021)

Figure 248: Varicella Zoster Infection Treatment Market Split By Route of Administration (2021)

Figure 249: Varicella Zoster Infection Treatment Market Split By Distribution Channel (2021)

Figure 250: Varicella Zoster Infection Treatment Market Split By Country (2021)

Figure 251: MEA Varicella Zoster Infection Treatment Market Size Analysis, 2012-2021

Figure 252: MEA Varicella Zoster Infection Treatment Market Forecast & Y-o-Y growth, 2022-2028

Figure 253: GCC Countries Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 254: GCC Countries Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 255: South Africa Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 256: South Africa Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 257: North Africa Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 258: North Africa Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 259: Rest of MEA Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 260: Rest of MEA Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 261: Acyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 262: Acyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 263: Valacyclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 264: Valacyclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 265: Famciclovir Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 266: Famciclovir Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 267: Oral Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 268: Oral Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 269: Injectable Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 270: Injectable Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 271: Topical Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 272: Topical Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 273: Hospital Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 274: Hospital Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 275: Retail Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 276: Retail Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 277: Online Pharmacies Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 278: Online Pharmacies Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 279: Drug Stores Varicella Zoster Infection Treatment Market Size (US$ Mn) Analysis, 2012-2021

Figure 280: Drug Stores Varicella Zoster Infection Treatment Market Forecast & Y-o-Y Growth (%), 2022-2028

Figure 281: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 282: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 283: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 284: MEA Varicella Zoster Infection Treatment Market Attractiveness Analysis By Country, 2022-2028

Figure 285: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Region, 2022-2028

Figure 286: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Drug Type, 2022-2028

Figure 287: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Route of Administration, 2022-2028

Figure 288: Global Varicella Zoster Infection Treatment Market Attractiveness Analysis By Distribution Channel, 2022-2028

Figure 289: Global Varicella Zoster Infection Treatment Market Value Analysis and Forecast, 2012–2028 (US$ Mn)

Figure 290: Global Varicella Zoster Infection Treatment Market Absolute $ Opportunity (US$ Mn), 2012–2028

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Swab and Viral Transport Medium Market

Published : March 2022

Healthcare

Rare Inflammatory Disease Treatment Market

Published : December 2021

Healthcare

Genital Herpes Treatment Market

Published : July 2021

Google translate

Varicella Zoster Infection Treatment Market